Truqap is a kinase inhibitor that actually works by blocking pathways that enable the cancer cells endure and grow, so cuts down cancer development. Truqap is from a category of medicines termed an AKT inhibitor. Truqap gained FDA approval on November seventeen, 2023, following positive success with